Bookmark this page for the livestream of the second day of the impeachment proceedings against Vice President Sara Duterte on Tuesday, March 3Bookmark this page for the livestream of the second day of the impeachment proceedings against Vice President Sara Duterte on Tuesday, March 3

Sara Duterte impeachment case: 2 complaints undergo House’s substance test

2026/03/03 07:00
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

MANILA, Philippines – The House justice committee resumes deliberations on the impeachment complaints against Vice President Sara Duterte on Tuesday, March 3.

The committee is now down to two petitions, from the original four.

The remaining petitions, one endorsed by Mamamayang Liberal Representative Leila de Lima and the other endorsed by Deputy Speaker Paolo Ortega and Manila 6th District Representative Bienvenido Abante Jr., passed the test of form on Monday, March 2, and will now undergo a so-called substance test.

Sufficiency in substance means the facts constituting the offenses charged are articulated properly.

If either complaint passes that test, the justice committee would send Duterte a copy of the complaint and give her the opportunity to answer the allegations.

If the House declares both complaints insufficient in substance, the latest effort to remove Duterte from office would be deemed dead, earning her the constitutional one-year protection from impeachment.

The issues raised against Duterte in the new impeachment drive remain the same — her alleged misuse of confidential funds, her alleged bribery of education officials, her alleged unexplained wealth, and her apparent threats to the life of President Ferdinand Marcos Jr. and his family, among others.

The Vice President has issued blanket denials but has not responded in detail to each allegation. 

During Monday’s proceedings, the House “set aside” the complaint endorsed by Makabayan for having been filed days before February 6, which was the original date set by the Supreme Court as the expiry of the one-year bar against the Vice President.

Tindig Pilipinas, meanwhile, withdrew its complaint, supposedly to avoid further delays in the proceedings.

Bookmark this page for the livestream of day two of the impeachment proceedings at 10 am on Tuesday. – Rappler.com

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09